Product Information
PROCHLORPERAZINE 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1179 per EA under NDC 68462088901. Its NADAC has been published 141 times since Dec 13, 2023.
FDA first approved this application on Mar 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462088901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216595FDA Approved
3/17/2023
TE Code
AB
On Market Since
3/17/2023
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 5 MG TABLET has been published 141 times since Dec 13, 2023, and over the history we have for it it has declined 57.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1179 per EA |
|---|---|
| All-time high | $0.2871 (Feb 14, 2024) |
| All-time low | $0.1130 (Jul 22, 2026) |
| 52-week high | $0.1625 |
| 52-week low | $0.1130 |
| Median price | $0.1520 |
| Average price | $0.1647 |
| Largest weekly change | +71.7% (Aug 21, 2024) |
| Weeks tracked | 141 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1179 per EA (NDC 68462088901), effective Aug 19, 2026.
How has the price of PROCHLORPERAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 5 MG TABLET has declined 57.1%. It has been tracked across 141 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 5 MG TABLET?
Since Dec 13, 2023, the NADAC for PROCHLORPERAZINE 5 MG TABLET has ranged from a low of $0.1130 (Jul 22, 2026) to a high of $0.2871 (Feb 14, 2024), with a median of $0.1520 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 5 MG TABLET?
PROCHLORPERAZINE 5 MG TABLET (NDC 68462088901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.